We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+13.84%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.52B
AUM Growth
+$673M
Cap. Flow
-$326M
Cap. Flow %
-3.42%
Top 10 Hldgs %
9.28%
Holding
1,001
New
72
Increased
350
Reduced
347
Closed
95

Top Buys

Rank Stock Value
1
HELE icon
Helen of Troy
HELE
+$26.1M
2
ROG icon
Rogers Corp
ROG
+$16.2M
3
CLB icon
Core Laboratories
CLB
+$14.3M
4
HLIT icon
Harmonic Inc
HLIT
+$13.5M
5
MOV icon
Movado Group
MOV
+$13M

Sector Composition

Rank Sector Weight
1 Industrials 27.63%
2 Technology 17.45%
3 Financials 12.95%
4 Consumer Discretionary 12.77%
5 Materials 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPH
451
DELISTED
Tri Pointe Homes
TPH
$5.34M 0.06%
287,428
-4,400
-2% -$76.5K
RCKY icon
452
Rocky Brands
RCKY
$366M
$5.33M 0.06%
225,610
-78,173
-26% -$1.81M
AXNX
453
DELISTED
Axonics, Inc. Common Stock
AXNX
$5.32M 0.06%
85,000
-4,000
-4% -$265K
RNGR icon
454
Ranger Energy Services
RNGR
$363M
$5.3M 0.06%
481,772
+30,000
+7% +$316K
CIVI
455
DELISTED
Civitas Resources
CIVI
$5.3M 0.06%
91,530
+22,830
+33% +$1.47M
UNTY icon
456
Unity Bancorp
UNTY
$589M
$5.3M 0.06%
193,749
+54,874
+40% +$1.51M
TRST
457
Trustco Bank Corp NY
TRST
$963M
$5.29M 0.06%
140,651
+20,000
+17% +$730K
FRPT icon
458
Freshpet
FRPT
$2.98B
$5.28M 0.06%
100,000
CORT icon
459
Corcept Therapeutics
CORT
$12.7B
$5.27M 0.06%
259,474
-13,239
-5% -$332K
MBUU icon
460
Malibu Boats
MBUU
$550M
$5.26M 0.06%
98,691
+17,400
+21% +$933K
NPKI
461
NPK International
NPKI
$1.05B
$5.21M 0.05%
1,256,400
ITGR icon
462
Integer Holdings
ITGR
$3.42B
$5.18M 0.05%
75,700
UFPT icon
463
UFP Technologies
UFPT
$1.97B
$5.15M 0.05%
43,720
-16,200
-27% -$1.73M
TILE icon
464
Interface
TILE
$1.96B
$5.15M 0.05%
521,383
-76,400
-13% -$803K
IBEX icon
465
IBEX
IBEX
$475M
$5.13M 0.05%
206,444
-2,230
-1% -$50.3K
EGLE
466
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$5.1M 0.05%
102,117
+5,991
+6% +$300K
SNA icon
467
Snap-on
SNA
$21.2B
$5.08M 0.05%
22,250
GT icon
468
Goodyear
GT
$2.04B
$5.06M 0.05%
499,000
-101,076
-17% -$1.1M
HONE
469
DELISTED
HarborOne Bancorp
HONE
$5.04M 0.05%
362,905
-5,000
-1% -$71.2K
CCS icon
470
Century Communities
CCS
$1.95B
$5M 0.05%
100,034
-2,000
-2% -$94.6K
BBBY
471
Bed Bath & Beyond
BBBY
$472M
$4.94M 0.05%
+280,775
New +$6.04M
TOL icon
472
Toll Brothers
TOL
$14B
$4.94M 0.05%
98,898
-1,700
-2% -$78.2K
QCRH icon
473
QCR Holdings
QCRH
$1.69B
$4.94M 0.05%
99,423
-25,538
-20% -$1.32M
DOCS icon
474
Doximity
DOCS
$3.82B
$4.91M 0.05%
146,160
-234,868
-62% -$7.17M
FOCS
475
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$4.9M 0.05%
131,460
+81,460
+163% +$2.9M

Similar funds

Royce & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Royce & Associates held 1,001 positions worth $9.52B, up 7.6% from $8.84B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2022, closing 95 positions and reducing 347 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $58.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Rogers Corp worth $12.4M.

  • Royce & Associates's largest Q4 2022 buy was Rogers Corp: 104,264 shares worth $12.4M.
  • Royce & Associates added most to Helen of Troy in Q4 2022, an estimated $26.1M increase.
  • Royce & Associates's biggest Q4 2022 reduction was Kulicke & Soffa, cutting an estimated $39.9M.
  • Royce & Associates fully exited IAA, Inc. Common Stock in Q4 2022, selling an estimated $58.3M.
  • Royce & Associates's ten largest holdings make up 9.3% of its $9.52B portfolio in Q4 2022.
  • Royce & Associates opened 72 new positions and closed 95 in Q4 2022.
  • Royce & Associates's portfolio value rose 7.6% quarter-over-quarter to $9.52B.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.